Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to evaluate the efficacy and safety of desflurane (BLM-240) as
an anesthetic agent and to demonstrate the non-inferiority of desflurane to sevoflurane in
term of awakening/recovery from anesthesia.